Statistics

Total Visits

Views
Sustained efficacy of ustekinumab in refractory erythrodermic psoriasis after failure of antitumor necrosis factor therapies55

Select a period of time:

Number of views in the range

Views
Sustained efficacy of ustekinumab in refractory erythrodermic psoriasis after failure of antitumor necrosis factor therapies35

Views

Views
January 20255
February 20252
March 202514
April 20254
May 20250
June 20250
July 202510
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore18
United States8
Brazil4
Hong Kong2
Spain1
United Kingdom1
South Africa1
 

Top cities views

Views
Los Angeles2
Hong Kong2
Cape Town1
Council Bluffs1
Dayton1
Diadema1
Indaiatuba1
Nova Friburgo1
Palmas1
Pasadena1